Abstract
Injectable biomaterials have shown promise for cardiac regeneration therapy. However, little is known regarding their retention and distribution upon application in vivo. Matrix imaging would be useful for evaluating these important properties. Herein, hexadecyl-4-[(18)F]fluorobenzoate ((18)F-HFB) and Qdot labeling was used to evaluate collagen matrix delivery in a mouse model of myocardial infarction (MI). At 1 wk post-MI, mice received myocardial injections of (18)F-HFB- or Qdot-labeled matrix to assess its early retention and distribution (at 10 min and 2h) by positron emission tomography (PET), or fluorescence imaging, respectively. PET imaging showed that the bolus of matrix at 10 min redistributed evenly within the ischemic territory by 2h. Ex vivo biodistribution revealed myocardial matrix retention of ∼ 65%, which correlated with PET results, but may be an underestimate since (18)F-HFB matrix labeling efficiency was ∼ 82%. For covalently linked Qdots, labeling efficiency was ∼ 96%. Ex vivo Qdot quantification showed that ∼ 84% of the injected matrix was retained in the myocardium. Serial non-invasive PET imaging and validation by fluorescence imaging confirmed the effectiveness of the collagen matrix to be retained and ...Continue Reading
References
Oct 26, 2005·Nuclear Medicine and Biology·Bing MaMichael R Kilbourn
Jan 18, 2006·Tissue Engineering·Ngan F HuangRandall J Lee
Nov 30, 2006·Circulation·Samuel T WallJulius M Guccione
Oct 22, 2008·Acta Biomaterialia·Stephen F BadylakThomas W Gilbert
Jan 13, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Erik J SuuronenMarc Ruel
Jul 16, 2010·Journal of Cardiovascular Translational Research·Jennifer M Singelyn, Karen L Christman
May 17, 2011·Journal of Molecular and Cellular Cardiology·Drew KuraitisErik J Suuronen
Aug 23, 2011·Nature Materials·Natalie ArtziElazer R Edelman
Oct 22, 2011·Biomaterials·Drew KuraitisErik J Suuronen
Jan 6, 2012·The New England Journal of Medicine·Elizabeth G Nabel, Eugene Braunwald
Apr 13, 2012·Biomaterials·Emilio I AlarconJuan C Scaiano
Nov 13, 2012·Expert Opinion on Drug Delivery·Todd D Johnson, Karen L Christman
Jan 8, 2013·Nature Biotechnology·Hak Soo ChoiJohn V Frangioni
Feb 12, 2013·International Journal of Cardiology·Lik Chuan LeeJulius M Guccione
Feb 22, 2013·Science Translational Medicine·Sonya B Seif-NaraghiKaren L Christman
May 4, 2013·International Journal for Numerical Methods in Biomedical Engineering·Renee MillerThomas Franz
Aug 6, 2013·Mayo Clinic Proceedings·Milica Radisic, Karen L Christman
Nov 15, 2013·Lancet·Nikhil V JoshiDavid E Newby
Jan 11, 2014·Biotechnology Advances·Janani RadhakrishnanSwaminathan Sethuraman
Feb 27, 2014·Advanced Functional Materials·Marianne E MertensTwan Lammers
Mar 19, 2014·Biomaterials·Ali AhmadiErik J Suuronen
Dec 30, 2014·Biomaterials·Alexandra BerdichevskiDror Seliktar
Citations
Jul 6, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Etienne CroteauRobert A deKemp
Nov 17, 2017·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Louise KiruGuillem Pratx
Apr 2, 2019·Critical Reviews in Biotechnology·Drew KuraitisErik J Suuronen
Mar 19, 2015·Biomedical Materials·Yan ZhangErik J Suuronen
Mar 17, 2019·Drug Delivery and Translational Research·Wei-Qiang WuShu Lin
Aug 23, 2020·International Journal of Molecular Sciences·Saltanat SmagulArman Saparov
Oct 20, 2020·Dalton Transactions : an International Journal of Inorganic Chemistry·Nicol GuidolinZsolt Baranyai
Feb 16, 2021·Advanced Healthcare Materials·Maaike J G SchotmanPatricia Y W Dankers
Aug 4, 2021·Heart Failure Reviews·Thiagarajan HemalathaNiraikulam Ayyadurai
Feb 14, 2018·Biomacromolecules·Charmainne CrujeElizabeth R Gillies
Jan 20, 2021·ACS Biomaterials Science & Engineering·Justina PupkaiteErik J Suuronen